Double-Digit Drop in Sales, Profits Reported Due to Patent Expiration of Aricept: Eisai

May 17, 2012
According to the consolidated settlement of accounts for the fiscal year ended March 2012 announced by Eisai on May 15, sales decreased by 15.7% compared to the previous year to 647.976 billion yen, posting a double-digit drop due to the...read more